Advanced Medical Solutions Group (AMSL) Stock Overview

Develops, manufactures, and distributes products for the surgical, woundcare, and wound-closure markets in the United Kingdom, Germany, rest of Europe, the United States, and internationally. More details

AMSL fundamental analysis
Snowflake Score
Valuation	3/6
Future Growth	4/6
Past Performance	1/6
Financial Health	4/6
Dividends	0/6

Rewards

Trading at 49.4% below our estimate of its fair value

Earnings are forecast to grow 30.51% per year

Analysts in good agreement that stock price will rise by 20.3%

Risk Analysis

Significant insider selling over the past 3 months

Profit margins (4.1%) are lower than last year (8.5%)

AMSL Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

View Stock Community

Advanced Medical Solutions Group plc Competitors

Price History & Performance

Summary of share price highs, lows and changes for Advanced Medical Solutions Group
Historical stock prices
Current Share Price	UK£2.21
52 Week High	UK£2.29
52 Week Low	UK£1.96
Beta	0.71
1 Month Change	6.25%
3 Month Change	6.76%
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	11.73%

Recent updates

Shareholder Returns

	AMSL	GB Medical Equipment	GB Market
7D	0.9%	3.2%	2.2%
1Y	n/a	13.4%	13.4%

Return vs Industry: Insufficient data to determine how AMSL performed against the UK Medical Equipment industry.

Return vs Market: Insufficient data to determine how AMSL performed against the UK Market.

Price Volatility

Is AMSL's price volatile compared to industry and market?
AMSL volatility
AMSL Average Weekly Movement	4.7%
Medical Equipment Industry Average Movement	5.7%
Market Average Movement	4.7%
10% most volatile stocks in GB Market	10.8%
10% least volatile stocks in GB Market	2.4%

Stable Share Price: AMSL has not had significant price volatility in the past 3 months compared to the UK market.

Volatility Over Time: Insufficient data to determine AMSL's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1991	1,500	Chris Meredith	www.admedsol.com

Advanced Medical Solutions Group plc, together with its subsidiaries, develops, manufactures, and distributes products for the surgical, woundcare, and wound-closure markets in the United Kingdom, Germany, rest of Europe, the United States, and internationally. The company operates in two segments, Surgical and Woundcare. It offers surgical products, such as tissue adhesives, sutures, haemostats, internal fixation devices, infection control, and internal sealants under LiquiBand, RESORBA, LiquiBandFix8, LIQUIFIX, and Seal-G, Vitalitec, and ActivHeal brand names.

Advanced Medical Solutions Group plc Fundamentals Summary

How do Advanced Medical Solutions Group's earnings and revenue compare to its market cap?
AMSL fundamental statistics
Market cap	UK£476.32m
Earnings (TTM)	UK£9.12m
Revenue (TTM)	UK£220.30m

52.2x

P/E Ratio

2.2x

P/S Ratio

Is AMSL overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
AMSL income statement (TTM)
Revenue	UK£220.30m
Cost of Revenue	UK£105.33m
Gross Profit	UK£114.98m
Other Expenses	UK£105.85m
Earnings	UK£9.12m

Last Reported Earnings

Jun 30, 2025

Next Earnings Date

n/a

Earnings per share (EPS)	0.042
Gross Margin	52.19%
Net Profit Margin	4.14%
Debt/Equity Ratio	27.0%

How did AMSL perform over the long term?

See historical performance and comparison

Dividends

1.2%

Current Dividend Yield

63%

Payout Ratio

Does AMSL pay a reliable dividends?

See AMSL dividend history and benchmarks

When do you need to buy AMSL by to receive an upcoming dividend?
Advanced Medical Solutions Group dividend dates
Ex Dividend Date	Sep 25 2025
Dividend Pay Date	Oct 24 2025
Days until Ex dividend	11 days
Days until Dividend pay date	18 days

Does AMSL pay a reliable dividends?

See AMSL dividend history and benchmarks

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/10/05 17:39
End of Day Share Price	2025/10/03 00:00
Earnings	2025/06/30
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Advanced Medical Solutions Group plc is covered by 22 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Samuel England	Berenberg
Julie Simmonds	Canaccord Genuity
Keith Redpath	Cavendish

Advanced Medical Solutions Group plcBATS-CHIXE:AMSL Stock Report